
Lisa V. Cook
Examiner (ID: 13564, Phone: (571)272-0816 , Office: P/1678 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1678, 1641, 1677 |
| Total Applications | 1360 |
| Issued Applications | 799 |
| Pending Applications | 170 |
| Abandoned Applications | 416 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18871223
[patent_doc_number] => 11859010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/930143
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 26
[patent_no_of_words] => 33386
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930143 | Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof | Sep 6, 2022 | Issued |
Array
(
[id] => 18244529
[patent_doc_number] => 20230076840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => SYSTEM AND SENSOR ARRAY
[patent_app_type] => utility
[patent_app_number] => 17/901294
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901294 | SYSTEM AND SENSOR ARRAY | Aug 31, 2022 | Pending |
Array
(
[id] => 17947091
[patent_doc_number] => 20220334110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MULTIFUNCTIONAL BEADS AND METHODS OF USE FOR CAPTURING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/855000
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855000
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855000 | MULTIFUNCTIONAL BEADS AND METHODS OF USE FOR CAPTURING CELLS | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18294450
[patent_doc_number] => 20230104136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Early Detection Of Hepatocellular Carcinoma
[patent_app_type] => utility
[patent_app_number] => 17/808420
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808420 | Early Detection Of Hepatocellular Carcinoma | Jun 22, 2022 | Pending |
Array
(
[id] => 19625142
[patent_doc_number] => 12163964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Amyloid beta detection by mass spectrometry
[patent_app_type] => utility
[patent_app_number] => 17/839262
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23497
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839262 | Amyloid beta detection by mass spectrometry | Jun 12, 2022 | Issued |
Array
(
[id] => 18933391
[patent_doc_number] => 11885808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase
[patent_app_type] => utility
[patent_app_number] => 18/044172
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 10307
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044172
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044172 | Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase | May 19, 2022 | Issued |
Array
(
[id] => 17961354
[patent_doc_number] => 20220341935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING, GERMLINE MISMATCH REPAIR DEFICIENCIES, LYNCH SYNDROME AND ASSESSING GERMLINE RISKS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/748522
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748522
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748522 | Methods and compositions for diagnosing and treating, germline mismatch repair deficiencies, lynch syndrome and assessing germline risks of cancer | May 18, 2022 | Issued |
Array
(
[id] => 17836490
[patent_doc_number] => 20220273795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/743995
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743995 | Constrained conditionally activated binding proteins | May 12, 2022 | Issued |
Array
(
[id] => 18603452
[patent_doc_number] => 11744892
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Constrained conditionally activated binding proteins
[patent_app_type] => utility
[patent_app_number] => 17/743961
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 122
[patent_no_of_words] => 20742
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743961
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743961 | Constrained conditionally activated binding proteins | May 12, 2022 | Issued |
Array
(
[id] => 17807477
[patent_doc_number] => 20220259312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY
[patent_app_type] => utility
[patent_app_number] => 17/739278
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739278 | Checkpoint blockade and microsatellite instability | May 8, 2022 | Issued |
Array
(
[id] => 18545328
[patent_doc_number] => 11718668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Checkpoint blockade and microsatellite instability
[patent_app_type] => utility
[patent_app_number] => 17/739274
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 11549
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739274 | Checkpoint blockade and microsatellite instability | May 8, 2022 | Issued |
Array
(
[id] => 17947101
[patent_doc_number] => 20220334120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Tissue-Derived Extracellular Vesicles and Their Use as Diagnostics
[patent_app_type] => utility
[patent_app_number] => 17/731833
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731833 | Tissue-Derived Extracellular Vesicles and Their Use as Diagnostics | Apr 27, 2022 | Pending |
Array
(
[id] => 18333479
[patent_doc_number] => 20230125427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/720067
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720067 | Methods of measuring signaling pathway activity for selection of therapeutic agents | Apr 12, 2022 | Issued |
Array
(
[id] => 18981368
[patent_doc_number] => 11906532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Hemostasis measurement device quality control formulations
[patent_app_type] => utility
[patent_app_number] => 17/703354
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8675
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/703354 | Hemostasis measurement device quality control formulations | Mar 23, 2022 | Issued |
Array
(
[id] => 17808718
[patent_doc_number] => 20220260553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING, GERMLINE MISMATCH REPAIR DEFICIENCIES, LYNCH SYNDROME AND ASSESSING GERMLINE RISKS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/674400
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674400
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/674400 | Methods and compositions for diagnosing and treating, germline mismatch repair deficiencies, lynch syndrome and assessing germline risks of cancer | Feb 16, 2022 | Issued |
Array
(
[id] => 19136464
[patent_doc_number] => 11971410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Methods of classifying response to immunotherapy for cancer
[patent_app_type] => utility
[patent_app_number] => 17/651235
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 16
[patent_no_of_words] => 9949
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651235 | Methods of classifying response to immunotherapy for cancer | Feb 14, 2022 | Issued |
Array
(
[id] => 18286237
[patent_doc_number] => 20230101709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PIPETTABLE REPLACEMENT FLUID FOR MIMICKING PIPETTABILITY OF TARGET FLUID AND RELATED METHOD
[patent_app_type] => utility
[patent_app_number] => 17/665514
[patent_app_country] => US
[patent_app_date] => 2022-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665514
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665514 | PIPETTABLE REPLACEMENT FLUID FOR MIMICKING PIPETTABILITY OF TARGET FLUID AND RELATED METHOD | Feb 4, 2022 | Abandoned |
Array
(
[id] => 17613036
[patent_doc_number] => 20220155316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => PROTEIN SEQUENCING METHODS AND REAGENTS
[patent_app_type] => utility
[patent_app_number] => 17/588754
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588754 | PROTEIN SEQUENCING METHODS AND REAGENTS | Jan 30, 2022 | Pending |
Array
(
[id] => 18059365
[patent_doc_number] => 20220390451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => SINGLE CELL GENOMIC PROFILING OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC DISEASE TO CHARACTERIZE DISEASE HETEROGENEITY
[patent_app_type] => utility
[patent_app_number] => 17/579437
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579437
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579437 | SINGLE CELL GENOMIC PROFILING OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC DISEASE TO CHARACTERIZE DISEASE HETEROGENEITY | Jan 18, 2022 | Abandoned |
Array
(
[id] => 19702738
[patent_doc_number] => 12196757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Autoantibody biomarkers for the early detection of ovarian cancer
[patent_app_type] => utility
[patent_app_number] => 17/563279
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6919
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563279 | Autoantibody biomarkers for the early detection of ovarian cancer | Dec 27, 2021 | Issued |